Skip to main content

Table 4 Clinical and genetic characteristics of syndromic TAAD patients and related mutation carriers

From: Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations

Family

Position on pedigree-status

Sex

Age

Ectopia lentis

Systemic score

CVS-involvement of the aorta

Aortic root

Z-score

IA

Extension

Age at surgerya

Type of surgerya

CVS-other

Type of syndrome

Gene

 

Mutation

TAAD032

III:2-proband

F

21

0

4

TAA

36

2.6

0

R

NA

  

MFS

FBN1

c.6740-2A > G

TAAD032

II:2-mother

F

53

0

3

TAA

39

2.7

1

R

NA

  

MFS

FBN1

c.6740-2A > G

TAAD001

II:9-proband

F

43

0

7

AAD

47

5.7

1

R, As, Ar, D, Ab

39

SC + A

 

MFS

FBN1

p.N2502X

TAAD012

II:6-proband

F

32

1

2

TAA

50

7.6

0

R

32

Dav

 

MFS

FBN1

p.C1408F

TAAD012

II:5-twin sibling

F

32

1

5

TAA

51

8.1

0

R

28

Dav

 

MFS

FBN1

p.C1408F

TAAD080

II:1-proband

M

48

0

NE

AAD

Surgery

 

0

R, As, Ar, D

42

AVR + SC

 

MFS

FBN1

p.I2585T

TAAD080

I:1-father

M

76

0

0

AAA

36

0.0

1

No

60

ABBG

 

MFS

FBN1

p.I2585T

TAAD080

II:4-sister

F

48

0

0

N

33

0.8

0

No

NA

  

MFS mutation carrier

FBN1

p.I2585T

TAAD080

II:8-sister

F

37

0

3

N

34

1.7

0

No

NA

  

MFS mutation carrier

FBN1

p.I2585T

TAAD080

III:8-niece

F

16

0

2

N

30

0.8

1

No

NA

  

Potential MFS

FBN1

p.I2585T

TAAD080

III:3-daughter

F

15

0

2

N

33

2.1

0

R

NA

  

Potential MFS

FBN1

p.I2585T

TAAD017

III:1-proband

M

42

1

6

TAA

48

4.2

1

R, As

NA

  

MFS

FBN1

p.R1692del

TAAD017

II:1-father

M

66

0

4

N

42

1.4

1

R

NA

  

MFS mutation carrier

FBN1

p.R1692del

TAAD056

II:4-proband

F

61

0

2

TAA

57

9.2

3

R, As, Ar

58

B

 

MFS

FBN1

p.Y2639C

TAAD056

III:3-daughter

F

28

0

5

TAA

44

4.8

0

R

NA

  

MFS

FBN1

p.Y2639C

TAAD038

III:2-proband

M

22

0

5

TAA

41

3.2

0

R

NA

 

MVP, MR 2+

MFS

FBN1

p.G744E

TAAD038

II:3-father

M

48

0

3

TAA

43

2.4

0

R

NA

 

MVP, MR 1+

MFS

FBN1

p.G744E

TAAD153

II:2-proband

F

48

0

1

TAA

46

5.7

3

R, As, Ar

48

B

 

MFS

FBN1

p.V984I

TAAD153

I:3-mother

F

72

0

5

N

35

1.2

1

No

NA

  

MFS mutation carrier

FBN1

p.V984I

TAAD153

IV:1-son

M

22

0

0

N

32

−0.4

0

No

NA

  

MFS mutation carrier

FBN1

p.V984I

TAAD153

IV:2-son

M

21

0

0

N

29

−1.2

0

No

NA

  

MFS mutation carrier

FBN1

p.V984I

TAAD108

proband

M

18

0

10

TAA

Surgery

 

1

R

19

B

 

MFS

Not found

NA

TAAD118

III:7-proband

M

26

0

8

TAA

Surgery

 

0

R, As

18

D

 

LDS

TGFBR1

p.A202 V

TAAD048

III:4-proband

F

42

0

0

AAD

Surgery

 

1

R, As, Ar, D, Ab

40

SC

 

LDS

TGFBR2

p.A527T

TAAD048

III:1 - brother

M

43

0

4

N

36

0.7

0

no

NA

  

LDS mutation carrier

TGFBR2

p.A527T

TAAD048

IV:3-daughter

F

19

0

7

Borderline TAA

36

2.8

0

R

NA

  

LDS

TGFBR2

p.A527T

TAAD048

IV:4-son

M

16

0

7

Borderline TAA

38

2.7

0

R

NA

  

LDS

TGFBR2

p.A527T

TAAD146

II:1-proband

M

26

0

10

TAA

49

5.6

1

R

NA

 

MVP, MR 2+

SGS

SKI

p.T20 K

  1. AAA abdominal aortic aneurysm, AAD acute aortic dissection, Ab abdominal aorta, ABBG aorto–bifemoral bypass grafting, Ar aortic arch, AVR aortic valve replacement, B Bentall procedure, CVS cardiovascular system, Dav David procedure, D thoracic descending aorta, F female, LDS Loyes-Dietz syndrome, M male, MR mitral regurgitation (0 none, 1 mild, 2 moderate, 3 severe), MFS Marfan syndrome, N normal echocardiographic study, NA not applicable, NE not examined, R aortic root, SC supracoronary ascending aortic replacement, SC + A supracoronary and arch prosthesis, SGS Shprintzen–Goldberg syndrome, TAA thoracic aortic aneurysm
  2. aRelates to primary surgical intervention